Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma. A Multicenter, Open Label Phase II Trial With Two Cohorts

NCT03937843 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT03937843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03937843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma. A Multicenter, Open Label Phase II Trial With Two Cohorts
Lead sponsor
Swiss Cancer Institute
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 29, 2019
Completion date
December 31, 2046
Enrollment
135 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

seminoma, testicular cancer